4-(2-fluorophenyl)-6-(thiophen-2-yl)pyrimidin-2-amine, 95.0%, 10g

2-(Bromomethyl)nicotinonitrile, 95.0%, 5g

Lauric Acid>98.0%(GC)(T)500g

(E)-N-(4-((4-Chloro-3-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide (Dacomitinib Impurity), 97%, 50mg

2-Propenamide, N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)-1-piperazinyl]phenyl]amino]-8-quinazolinyl]phenyl]-, 25mg

N-([1,1'-Biphenyl]-4-yl)-9,9-diphenyl-9H-fluoren-2-amine, 97%, 25g

1-Nitronaphthalen-2-ol, 95.0%, 5g

8-Fluoroquinoline, 98.0%, 10g

2,4-Dichloro-5-pyrimidinecarboxylic acid, 95.0%, 1g

FLUPIRTINE MALEATE, 95%, 25g

2-Chloro-5,6-dimethyl-1,3-benzothiazole, 95.0%, 250mg

Ethyl Benzoylformate>96.0%(GC)5mL

Viscosity standard S200, ROTI®Calipure, 540 cSt (20 °C), 500 ml, glass packaging